Claro Advisors LLC Acquires 310 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Claro Advisors LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.3% during the third quarter, Holdings Channel reports. The institutional investor owned 1,213 shares of the medical equipment provider’s stock after purchasing an additional 310 shares during the quarter. Claro Advisors LLC’s holdings in Intuitive Surgical were worth $596,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the period. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter valued at about $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. LRI Investments LLC acquired a new position in Intuitive Surgical during the 1st quarter worth $30,000. Finally, LGT Financial Advisors LLC lifted its stake in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company’s stock, valued at $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, General Counsel Gary Loeb sold 300 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the sale, the general counsel now owns 1,595 shares of the company’s stock, valued at approximately $757,625. The trade was a 15.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,178 shares of company stock worth $45,897,071. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 1.9 %

NASDAQ:ISRG opened at $527.61 on Monday. Intuitive Surgical, Inc. has a 12-month low of $295.02 and a 12-month high of $544.38. The stock’s 50 day moving average price is $499.29 and its two-hundred day moving average price is $458.50. The firm has a market capitalization of $187.92 billion, a price-to-earnings ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

ISRG has been the topic of several recent research reports. Citigroup raised their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. Mizuho boosted their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Finally, Truist Financial upped their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.